Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04471974
Title ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Rahul Aggarwal
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California, San Francisco RECRUITING San Francisco California 94143 United States Details
University of Chicago RECRUITING Evergreen Park Illinois 60805 United States Details
University of Michigan RECRUITING Ann Arbor Michigan 48109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field